Follow-The-Filings

Security

ANTX

An2 Therapeutics Inc. · COM

Equity holders as of 2026 Q1 (each manager’s latest book)

6 owners 1 new max 0.0% (Israel Englander - Millen...)

grid → activity →
owners 6
max % 0.0%
tracked value $10M
qoq N 1 A 2 R 1

holders

sorted by % of portfolio · long equity only

manager % port activity shares value history
Israel Englander - Millennium Management LLC 2026 Q1 0.0% Add 0.00 pp 2,222,502 $8M hist
Vanguard Group Inc. 2025 Q4 stale 0.0% — 1,080,070 $1M hist
Renaissance Technologies LLC 2026 Q1 0.0% Reduce 0.00 pp 198,800 $680 hist
Ken Griffin - Citadel Advisors LLC 2026 Q1 0.0% Add 0.00 pp 155,239 $531 hist
Two Sigma Investments, LP 2025 Q4 stale 0.0% Exit 0.00 pp 178,518 $204 hist
Marshall Wace - Marshall Wace, LLP 2026 Q1 0.0% New 0.0% 17,700 $61 hist

6 current · options excluded

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue — — —
Gross profit — — —
Gross margin — — —
Net income -$64.73M -$51.32M -$35.17M
Net margin — — —

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $110.51M $86.26M $59.94M
Total non-current assets * $28.24M $5.82M $2.01M
Total assets $138.74M $92.09M $61.95M
Total current liabilities $14.04M — $8.72M
Total non-current liabilities * $0.00 — $170,000
Total equity $124.7M $81.85M $53.06M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$53.29M -$49.26M -$29.83M
Cash from investing -$43.28M $54.59M $28.31M
Cash from financing $84.99M $372,000 $113,000
Net change in cash -$11.57M $5.7M -$1.41M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders